These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 22327134)

  • 41. Characterization of acute graft-versus-host disease following reduced-intensity stem-cell transplantation from an HLA-identical related donor.
    Murashige N; Kami M; Mori S; Katayama Y; Kobayashi K; Onishi Y; Hori A; Kishi Y; Hamaki T; Tajima K; Kanda Y; Tanosaki R; Takaue Y
    Am J Hematol; 2008 Aug; 83(8):630-4. PubMed ID: 18454459
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The graft-versus-leukemia effect is mainly restricted to NIH-defined chronic graft-versus-host disease after reduced intensity conditioning before allogeneic stem cell transplantation.
    Thepot S; Zhou J; Perrot A; Robin M; Xhaard A; de Latour RP; Ades L; Ribaud P; Petropoulou AD; Porcher R; Socié G
    Leukemia; 2010 Nov; 24(11):1852-8. PubMed ID: 20827288
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Induction of aGVHD after allogeneic hematopoietic stem cell transplantation for refractory or relapsed acute leukemia].
    Sun J; Meng FY; Liu QF; Xu D; Xu B; Liu XL
    Ai Zheng; 2003 Dec; 22(12):1321-4. PubMed ID: 14693060
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Severe oral chronic graft-versus-host disease following allogeneic bone marrow transplantation: highly effective treatment with topical tacrolimus.
    Eckardt A; Starke O; Stadler M; Reuter C; Hertenstein B
    Oral Oncol; 2004 Sep; 40(8):811-4. PubMed ID: 15288836
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Effects and prognostic factors of HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia].
    Tong XZ; Li J; Tan EX; Zhang GC; Wu XY; Peng AH; Zheng D; Zou WY; Hong WD; Luo SK
    Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):545-8. PubMed ID: 17147125
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Clinical study of allogeneic hematopoietic stem cell transplantation for relapsed/refractory acute lymphocytic leukemia].
    Ma X; Wu DP; Sun AN; Fu ZZ; Tang XW; Wu XJ; Liu YJ; Qiu HY; Miao M; Han Y; Jin ZM; Zhao Y; Xue SL; Wang Y; Chen SN; He GS; Zhou HX; Chang HR
    Zhonghua Xue Ye Xue Za Zhi; 2009 Feb; 30(2):73-6. PubMed ID: 19563014
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A significant role of stromal fibroblasts in rapidly progressive dry eye in patients with chronic GVHD.
    Ogawa Y; Yamazaki K; Kuwana M; Mashima Y; Nakamura Y; Ishida S; Toda I; Oguchi Y; Tsubota K; Okamoto S; Kawakami Y
    Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):111-9. PubMed ID: 11133855
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Liver biopsy in the management of liver dysfunction after allogeneic hematopoietic stem-cell transplantation].
    Chen H; Huang XJ; Liu KY; Xu LP; Wang H; Liu DH; Lu J; Lu DP
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3062-6. PubMed ID: 16324408
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunotherapy of recurrent B-cell malignancies after allo-SCT with Bi20 (FBTA05), a trifunctional anti-CD3 x anti-CD20 antibody and donor lymphocyte infusion.
    Buhmann R; Simoes B; Stanglmaier M; Yang T; Faltin M; Bund D; Lindhofer H; Kolb HJ
    Bone Marrow Transplant; 2009 Mar; 43(5):383-97. PubMed ID: 18850012
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Effects of allogeneic hematopoietic stem cell transplantation with very-high-dose conditioning regimen for refractory leukemia].
    Liu QF; Sun J; Xu D; Zhang Y; Fan ZP; Wei YQ; Meng FY; Zhou SY
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Oct; 24(10):1117-9. PubMed ID: 15485779
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of allogeneic hematopoietic stem-cell transplantation in chronic lymphocytic leukemia.
    Gribben JG
    J Clin Oncol; 2008 Oct; 26(30):4864-5. PubMed ID: 18794537
    [No Abstract]   [Full Text] [Related]  

  • 52. The involvement of epithelial Fas in a human model of graft versus host disease.
    Ruffin N; Ahmed SS; Osorio LM; Wang XN; Jackson GH; Collin MP; Ekre HP; Chiodi F; Dickinson AM
    Transplantation; 2011 May; 91(9):946-51. PubMed ID: 21403589
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tortoise shell-like mucosa of acute intestinal graft-versus-host disease.
    Hokama A; Tomoyose T; Hirata T; Shimoji K; Kinjo T; Kishimoto K; Masuzaki H; Fujita J
    Clin Res Hepatol Gastroenterol; 2014 Oct; 38(5):543-4. PubMed ID: 24767609
    [No Abstract]   [Full Text] [Related]  

  • 54. Eruptive angiomatous lesions associated with graft-versus-host disease.
    Adamski H; Le Gall F; Cartron L; Dauriac C; Lancien G; Wechsler J; Ollivier I; Lachgar S; Dosquet C; Coudert MC; Chevrant-Breton J
    Br J Dermatol; 2003 Sep; 149(3):667-8. PubMed ID: 14511016
    [No Abstract]   [Full Text] [Related]  

  • 55. Granulocytic sarcoma and chronic lymphocytic leukemia of the gastrointestinal tract after allogeneic hematopoietic cell transplantation mimicking graft-versus-host disease.
    Raychaudhuri J; Cualing H; Haider K; Kharfan-Dabaja MA
    Leuk Lymphoma; 2008 Feb; 49(2):350-2. PubMed ID: 18231925
    [No Abstract]   [Full Text] [Related]  

  • 56. Is single-cell apoptosis sufficient for the diagnosis of graft-versus-host disease in the colon?
    Nguyen CV; Kastenberg DM; Choudhary C; Katz LC; DiMarino A; Palazzo JP
    Dig Dis Sci; 2008 Mar; 53(3):747-56. PubMed ID: 18060495
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Skin allograft for severe chronic GvHD.
    Crocchiolo R; Dubois V; Nicolini FE; Sobh M; Ducastelle-Lepretre S; Labussiere H; Lebras L; Auxenfans C; Mojallal A; Damour O; Braye F; Michallet M
    Bone Marrow Transplant; 2017 Jul; 52(7):1060-1062. PubMed ID: 28346413
    [No Abstract]   [Full Text] [Related]  

  • 58. To the end of chronic lymphocytic leukemia: what should be the role of allogeneic transplant?
    van Besien K; Furman RR
    Leuk Lymphoma; 2014 Jun; 55(6):1221-2. PubMed ID: 24745938
    [No Abstract]   [Full Text] [Related]  

  • 59. Ileostomy for steroid-resistant acute graft-versus-host disease of the gastrointestinal tract.
    Turki AT; Bayraktar E; Basu O; Benkö T; Yi JH; Kehrmann J; Tzalavras A; Liebregts T; Beelen DW; Steckel NK
    Ann Hematol; 2019 Oct; 98(10):2407-2419. PubMed ID: 31338570
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Surgical resection as definitive treatment for refractory GVHD of the colon.
    Cornell RF; Palmer J; Komorowski R; Drobyski WR
    Bone Marrow Transplant; 2012 Oct; 47(10):1366-7. PubMed ID: 22327134
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.